ExodusPoint Capital Management’s Neuronetics STIM Stock Holding History

ExodusPoint Capital Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,203	Closed	-$20.6K	–	2041
2026 Q1	$20.6K	Sell	14,203 -58,181	-80%	-$92.2K	﹤0.01%	1474
2025 Q4	$99.9K	Hold	72,384	–	–	﹤0.01%	1438
2025 Q3	$198K	Buy	+72,384	New	+$257K	﹤0.01%	1389
2025 Q2	–	Sell	-14,603	Closed	-$54K	–	1949
2025 Q1	$54K	Buy	+14,603	New	+$53.3K	﹤0.01%	1367
2021 Q2	–	Sell	-58,263	Closed	-$721K	–	2782
2021 Q1	$721K	Buy	58,263 +28,675	+97%	+$440K	0.01%	1121
2020 Q4	$329K	Buy	+29,588	New	+$222K	﹤0.01%	1494

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ExodusPoint Capital Management's STIM Position: Q2 2026 in Review

ExodusPoint Capital Management sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 14,203 shares — an estimated $20.6K sold.

ExodusPoint Capital Management first reported a position in STIM in Q4 2020 and held it in 6 quarters. The position peaked at $721K in Q1 2021. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

ExodusPoint Capital Management reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
ExodusPoint Capital Management sold 14,203 Neuronetics shares in Q2 2026, an estimated $20.6K.
ExodusPoint Capital Management first reported a position in Neuronetics in Q4 2020 and held it in 6 quarters.
ExodusPoint Capital Management's Neuronetics position peaked at $721K in Q1 2021.
86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.